New drug combo could make inoperable kidney tumors removable
Disease control
Recruiting now
This study tests whether a 12-week course of zanzalintinib (a pill) plus nivolumab (an immunotherapy) can shrink advanced kidney tumors enough to allow surgery. About 69 adults with locally advanced or inoperable clear cell renal cell carcinoma will receive the combination. After…
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated May 01, 2026 20:11 UTC